Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
about
Bacterial evolution in PCD and CF patients follows the same mutational stepsInterspecific Bacterial Interactions are Reflected in Multispecies Biofilm Spatial OrganizationPseudomonas aeruginosa biofilms in cystic fibrosisMicrobial communication, cooperation and cheating: quorum sensing drives the evolution of cooperation in bacteriaThe extracellular matrix Component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilmsCharacterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infection.Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro.Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patientsPhenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.Hydration-controlled bacterial motility and dispersal on surfaces.Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophiliaConditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infectionClinical significance of microbial infection and adaptation in cystic fibrosis.Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors.Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.The sociobiology of biofilms.Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis.A spider web strategy of type IV pili-mediated migration to build a fibre-like Psl polysaccharide matrix in Pseudomonas aeruginosa biofilmsMolecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patientsSocial evolution theory for microorganisms.In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections.The quorum quenching antibody RS2-1G9 protects macrophages from the cytotoxic effects of the Pseudomonas aeruginosa quorum sensing signalling molecule N-3-oxo-dodecanoyl-homoserine lactone.Evolutionary theory of bacterial quorum sensing: when is a signal not a signal?Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infectionPhenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran.Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals.Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in Pseudomonas aeruginosa clinical isolates from Recife, State of Pernambuco, Brazil.The role of bacterial biofilms in chronic infections.Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection.Methods for dynamic investigations of surface-attached in vitro bacterial and fungal biofilms.Evaluation of the role of substrate and albumin on Pseudomonas aeruginosa biofilm morphology through FESEM and FTIR studies on polymeric biomaterials.Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.
P2860
Q27334684-644CB0EA-C867-453C-887F-D9EAFD658BC1Q28066840-5CFA683C-F6C3-4338-B49E-3BB3CEC55BAAQ28299966-40FA5319-CF91-4D6A-8304-8100AFE78513Q28475939-476F452F-29A5-47A9-9D20-F6320189AB06Q28535199-0864749B-C569-4C5D-8739-D3939798A845Q31161151-F5B5EB12-FACE-4BF1-9CEF-9D7B25602FF5Q33530241-F9BDEF4A-37A6-4C2E-A27D-6F7E55D1EDE8Q33559774-339BB854-51D3-4C64-878C-3C484F6797DEQ33950924-40E5D50D-5FD7-4DF0-B766-1A9B02BF8903Q34069552-61AF5B7B-84D0-49AB-B027-118DE73FED62Q34082906-6895FCC4-C8BA-4467-86BC-474385B43875Q34128914-878E331A-91D3-4DE5-998D-FB55825722E7Q34294110-C33FD0A1-0762-48AB-A844-51F8813C3A3BQ34479389-54A026B4-7922-4827-BC90-B0A2B003C1ABQ34491552-4108A292-B595-4B67-9FAF-B298C27204B2Q34661901-71992456-EBE1-4C99-8D5D-0F940CDD08B4Q34693974-28792491-CDFA-4961-BB9A-5977F966FEA6Q34696678-6715FB02-3EB3-4CEC-9B5B-F409AF8F531AQ34757004-504A3E40-F2ED-4F9B-AED6-28F07314DE31Q34899346-AD7CBDF4-85EE-4540-A261-019C3E36243EQ35686899-D14CC283-E402-4444-A440-78A83885688BQ35738787-A1800D7E-9580-4FAC-A248-350F7EA5527DQ35784162-6BDE9087-9847-4C33-827B-65FB70F3F098Q36538101-3FE6CB77-C6C5-43E9-818B-4B2859B9910CQ36540547-F6523AB3-422E-4143-94DB-A3FECB0B5D8FQ36608383-46F214B8-F34B-4AD1-AC3D-C0E4885169E1Q36759779-8EB5E7FC-B80E-473F-974E-ACB0812A3DFBQ37067270-3142CEEF-066E-4B23-AFB0-92DD894D26BCQ37068359-51AF2AC0-7456-4A98-B97B-25736E59BB9FQ37342706-92EB3940-FAAF-4F4E-B364-4EB001C5394CQ37382721-5C5DA0A3-F584-48E0-9B55-40B6E3E3E420Q37413900-F14CE84E-6F7D-4AE6-9370-A49417DC6A99Q38006032-C7AF92E4-87D2-48A9-8ECA-B18CFAD4318EQ38807634-B813A84A-5030-4586-BA34-A93E84E5D105Q39113907-30C1658E-A09A-4E22-A0F6-A1ACB49D97BAQ39426830-595F56C6-B6C3-493A-A70B-C8ABDB21BD92Q39696154-1672754C-2D5C-4F56-A1D1-20AFC0321CF7Q39978500-EE816747-0A7A-4CB7-B14D-EF90D1893E10Q40347676-0859E5DD-B79A-4D63-9238-A3241DAAC2D4Q40964077-F3771198-68CA-4EF0-BE7C-81682BE2D873
P2860
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@en
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@nl
type
label
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@en
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@nl
prefLabel
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@en
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@nl
P2860
P50
P921
P1476
Heterogeneity of biofilms form ...... patients with cystic fibrosis.
@en
P2093
Baoleri Lee
Janus A J Haagensen
P2860
P304
P356
10.1128/JCM.43.10.5247-5255.2005
P407
P577
2005-10-01T00:00:00Z